+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

African-American men are at increased risk for presenting with clinically advanced prostate cancer Results from the prostate cancer outcomes study



African-American men are at increased risk for presenting with clinically advanced prostate cancer Results from the prostate cancer outcomes study



JGIM 14(Suppl. 2): 39




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034365863

Download citation: RISBibTeXText


Related references

Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study. Journal of Urology 174(2): 646-50; Discussion 650, 2005

Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. Journal of Clinical Oncology 19(9): 2517-2526, 2001

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence. Journal of Experimental and Clinical Cancer Research 32: 9, 2013

Predictors of overall and cancer-specific survival in patients with clinically localized prostate cancer (PC) treated with primary androgen deprivation therapy (PADT): Results from the Prostate Cancer Outcomes Study. Journal of Clinical Oncology 24(18_Suppl): 4610-4610, 2016

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. Bju International 109(Suppl. 1): 22-29, 2012

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. Bju International 110(10): E431-2; Author Reply E432, 2013

High grade prostate intraepithelial neoplasia (PIN) is a PSA-independent risk factor for prostate cancer in African American men: results from a pilot study. Cancer Letters 331(2): 154-157, 2013

Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. Journal of General Internal Medicine 18(10): 845-853, 2003

Increased non-prostate cancer death risk in clinically diagnosed prostate cancer. Bju International 110(2): 188-194, 2012

Prostate cancer screening in high-risk men: African American Hereditary Prostate Cancer Study Network. Cancer 106(4): 796-803, 2006

Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer. Bju International 96(1): 29-33, 2005

Racial difference in serum prostate specific antigen doubling time, histopathological variables and long-term PSA recurrence between African American and White American men undergoing radical prostatectomy for clinically localized prostate cancer. Journal of Urology 171(4 Suppl.): 272, 2004

Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men. Urology 76(5): 1058-1062, 2010

Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Cancer 97(7): 1653-1662, 2003

Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7. European Urology 70(4): 684-691, 2016